Liver Diseases  >>  Byetta (exenatide)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Byetta (exenatide) / AstraZeneca
NCT00529204: Effects Of Exenatide On Liver Biochemistry, Liver Histology And Lipid Metabolism In Patients With Fatty Liver Disease

Terminated
2
1
US
exenatide, BYETTA
University of California, Davis, Amylin Pharmaceuticals, LLC., Eli Lilly and Company
Diabetes Complications, Fatty Liver
07/09
02/10

Download Options